Immunohistochemical determination of HER-2/neu overexpression in malignant melanoma reveals no prognostic value, while c-Kit (CD117) overexpression exhibits potential therapeutic implications.

Anil Potti(University of North Dakota), Michael O. Koch
Journal of Carcinogenesis
January 1, 2003
Cited by 29


Related Papers